RAP 0.00% 20.5¢ resapp health limited

Ann: Pfizer raises scheme consideration to A$0.208 per share, page-72

  1. 3,464 Posts.
    lightbulb Created with Sketch. 956
    Why does the largest medical research companies on the planet want a failing Australian micro start up that failed in their opinion on one test?

    I can understand why posters who have come on board in last 2 years of Covid want this to be a Disallowed and encourage a Yes...

    To all the posters who have come on board in Covid times...

    Please take a kindness of the silver this company has brought to you.
    A premium of such joy for your silver.

    Please with kindness lay down your mouths...

    Vote No for the holders who have kept this RAP turning over and doing the research from the research done over 30 years or more.

    Play with kindness to long holders here. .

    Vote No
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.